FDA Approved: CARBOPLATIN — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application for generic carboplatin. This action permits Apotex to market a generic carboplatin formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of the Head and Neck
• Cervical Cancer
• Endometrial Cancer
• Esophageal Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

SUPPL AP for CARBOPLATIN (CARBOPLATIN)